辅仁药业(600781.SH)控股股东辅仁集团所持股份被轮候冻结
格隆汇6月18日丨辅仁药业(600781.SH)公布,公司收到中国证券登记结算有限公司上海分公司股权司法冻结通知(2019司冻0618-01号),根据河北省石家庄市中级人民法院协助执行通知书【(2019)冀01执保130号、131号】、广州市越秀区人民法院协助执行通知书【(2019)粤0104执16501号】、河南省开封市金明区人民法院协助执行通知书【(2019)豫0211民初1803号】、河南省郑州市中级人民法院协助执行通知书【(2019)豫01执保282号】,对控股股东辅仁药业集团有限公司(“辅仁集团”)所持有的公司无限售流通股约5401.50万股及限售流通股约2.2839亿股股份依次进行了轮候冻结。冻结期限3年,自转为正式冻结之日起计算。
截至目前,辅仁集团与一致行动人北京克瑞特投资中心(有限合伙)合计持有公司股份约3.0691亿股,占公司总股本比例为48.94%。辅仁集团持有公司股份约2.8240亿股,占公司总股本比例为45.03%,此次冻结后累计被冻结股份数量约2.1445亿股,占辅仁集团持有公司股份比例为75.94%,占公司总股本比例为34.19%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.